123 related articles for article (PubMed ID: 18815290)
1. Inherited and acquired variations in the hyaluronan synthase 1 (HAS1) gene may contribute to disease progression in multiple myeloma and Waldenstrom macroglobulinemia.
Adamia S; Reichert AA; Kuppusamy H; Kriangkum J; Ghosh A; Hodges JJ; Pilarski PM; Treon SP; Mant MJ; Reiman T; Belch AR; Pilarski LM
Blood; 2008 Dec; 112(13):5111-21. PubMed ID: 18815290
[TBL] [Abstract][Full Text] [Related]
2. Genetic abnormalities in Waldenström's macroglobulinemia.
Adamia S; Pilarski PM; Belch AR; Pilarski LM
Clin Lymphoma Myeloma; 2009 Mar; 9(1):30-2. PubMed ID: 19362966
[TBL] [Abstract][Full Text] [Related]
3. Inherited polymorphisms in hyaluronan synthase 1 predict risk of systemic B-cell malignancies but not of breast cancer.
Kuppusamy H; Ogmundsdottir HM; Baigorri E; Warkentin A; Steingrimsdottir H; Haraldsdottir V; Mant MJ; Mackey J; Johnston JB; Adamia S; Belch AR; Pilarski LM
PLoS One; 2014; 9(6):e100691. PubMed ID: 24950197
[TBL] [Abstract][Full Text] [Related]
4. Alteration of introns in a hyaluronan synthase 1 (HAS1) minigene convert Pre-mRNA [corrected] splicing to the aberrant pattern in multiple myeloma (MM): MM patients harbor similar changes.
Kriangkum J; Warkentin A; Belch AR; Pilarski LM
PLoS One; 2013; 8(1):e53469. PubMed ID: 23301075
[TBL] [Abstract][Full Text] [Related]
5. Potential impact of a single nucleotide polymorphism in the hyaluronan synthase 1 gene in Waldenstrom's macroglobulinemia.
Adamia S; Treon SP; Reiman T; Tournilhac O; McQuarrie C; Mant MJ; Belch AR; Pilarski LM
Clin Lymphoma; 2005 Mar; 5(4):253-6. PubMed ID: 15794859
[TBL] [Abstract][Full Text] [Related]
6. Intronic splicing of hyaluronan synthase 1 (HAS1): a biologically relevant indicator of poor outcome in multiple myeloma.
Adamia S; Reiman T; Crainie M; Mant MJ; Belch AR; Pilarski LM
Blood; 2005 Jun; 105(12):4836-44. PubMed ID: 15731173
[TBL] [Abstract][Full Text] [Related]
7. Abnormal expression of hyaluronan synthases in patients with Waldenstrom's macroglobulimenia.
Adamia S; Crainie M; Kriangkum J; Mant MJ; Belch AR; Pilarski LM
Semin Oncol; 2003 Apr; 30(2):165-8. PubMed ID: 12720129
[TBL] [Abstract][Full Text] [Related]
8. Characterization of hyaluronan synthase expression and hyaluronan synthesis in bone marrow mesenchymal progenitor cells: predominant expression of HAS1 mRNA and up-regulated hyaluronan synthesis in bone marrow cells derived from multiple myeloma patients.
Calabro A; Oken MM; Hascall VC; Masellis AM
Blood; 2002 Oct; 100(7):2578-85. PubMed ID: 12239172
[TBL] [Abstract][Full Text] [Related]
9. Aberrant posttranscriptional processing of hyaluronan synthase 1 in malignant transformation and tumor progression.
Adamia S; Kriangkum J; Belch AR; Pilarski LM
Adv Cancer Res; 2014; 123():67-94. PubMed ID: 25081526
[TBL] [Abstract][Full Text] [Related]
10. Aberrant splice variants of HAS1 (Hyaluronan Synthase 1) multimerize with and modulate normally spliced HAS1 protein: a potential mechanism promoting human cancer.
Ghosh A; Kuppusamy H; Pilarski LM
J Biol Chem; 2009 Jul; 284(28):18840-50. PubMed ID: 19451652
[TBL] [Abstract][Full Text] [Related]
11. Genomics and proteomics in multiple myeloma and Waldenström macroglobulinemia.
Henry T; Fonseca R
Curr Opin Hematol; 2007 Jul; 14(4):369-74. PubMed ID: 17534163
[TBL] [Abstract][Full Text] [Related]
12. Aberrant splicing, hyaluronan synthases and intracellular hyaluronan as drivers of oncogenesis and potential drug targets.
Adamia S; Pilarski PM; Belch AR; Pilarski LM
Curr Cancer Drug Targets; 2013 May; 13(4):347-61. PubMed ID: 23517594
[TBL] [Abstract][Full Text] [Related]
13. Gene-expression profiling of Waldenstrom macroglobulinemia reveals a phenotype more similar to chronic lymphocytic leukemia than multiple myeloma.
Chng WJ; Schop RF; Price-Troska T; Ghobrial I; Kay N; Jelinek DF; Gertz MA; Dispenzieri A; Lacy M; Kyle RA; Greipp PR; Tschumper RC; Fonseca R; Bergsagel PL
Blood; 2006 Oct; 108(8):2755-63. PubMed ID: 16804116
[TBL] [Abstract][Full Text] [Related]
14. The gene structure and promoter sequence of mouse hyaluronan synthase 1.
Yamada Y; Itano N; Zako M; Yoshida M; Lenas P; Niimi A; Ueda M; Kimata K
Biochem J; 1998 Mar; 330 ( Pt 3)(Pt 3):1223-7. PubMed ID: 9494089
[TBL] [Abstract][Full Text] [Related]
15. The human hyaluronan synthase genes: genomic structures, proximal promoters and polymorphic microsatellite markers.
Monslow J; Williams JD; Norton N; Guy CA; Price IK; Coleman SL; Williams NM; Buckland PR; Spicer AP; Topley N; Davies M; Bowen T
Int J Biochem Cell Biol; 2003 Aug; 35(8):1272-83. PubMed ID: 12757764
[TBL] [Abstract][Full Text] [Related]
16. Concomitant Waldenstrom macroglobulinemia and IgA plasmablastic myeloma in a patient with untreated IgM paraproteinemia: sequential development of biclonal B-cell neoplasms over a 10-year period in a single individual.
Wang E; Kulbacki E; Stoecker M
Hum Pathol; 2012 Jul; 43(7):1135-41. PubMed ID: 22404949
[TBL] [Abstract][Full Text] [Related]
17. Simultaneous presentation of Waldenström macroglobulinemia and multiple myeloma: multidisciplinary diagnosis, treatment and 30-month follow-up.
Carulli G; Ciancia EM; Azzarà A; Ottaviano V; Grassi S; Ciabatti E; Ferreri MI; Rocco M; Marini A; Petrini M
J Clin Exp Hematop; 2013; 53(1):29-36. PubMed ID: 23801131
[TBL] [Abstract][Full Text] [Related]
18. Expression of hyaluronan synthase 1 and distribution of hyaluronan during follicular atresia in pig ovaries.
Miyake Y; Sakurai M; Tanaka S; Tunjung WA; Yokoo M; Matsumoto H; Aso H; Yamaguchi T; Sato E
Biol Reprod; 2009 Feb; 80(2):249-57. PubMed ID: 18923162
[TBL] [Abstract][Full Text] [Related]
19. Gene expression profiling of B lymphocytes and plasma cells from Waldenström's macroglobulinemia: comparison with expression patterns of the same cell counterparts from chronic lymphocytic leukemia, multiple myeloma and normal individuals.
Gutiérrez NC; Ocio EM; de Las Rivas J; Maiso P; Delgado M; Fermiñán E; Arcos MJ; Sánchez ML; Hernández JM; San Miguel JF
Leukemia; 2007 Mar; 21(3):541-9. PubMed ID: 17252022
[TBL] [Abstract][Full Text] [Related]
20. Effects of leflunomide on hyaluronan synthases (HAS): NF-kappa B-independent suppression of IL-1-induced HAS1 transcription by leflunomide.
Stuhlmeier KM
J Immunol; 2005 Jun; 174(11):7376-82. PubMed ID: 15905585
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
